A parent's hardest week
Imagine sitting beside a newborn in the NICU after major chest surgery. Tubes. Monitors. A ventilator doing the breathing.
Now imagine the machine and your baby are not quite in sync. The numbers dip. The nurses adjust the settings. You try to stay calm.
This is the world of congenital diaphragmatic hernia (CDH — a hole in the breathing muscle that is present at birth). And a new study suggests a smarter ventilator might make this week a little easier.
CDH happens in about 1 in every 2,500 births. The hole in the diaphragm lets belly organs push up into the chest. That crowds the lungs and keeps them from growing properly.
Surgery closes the hole. But the lungs still need weeks of support to recover.
Getting ventilator settings right is one of the hardest parts of NICU care. Too much pressure can damage the fragile lungs. Too little, and the baby's oxygen drops.
Doctors have been looking for a better way.
The old way versus the new way
Standard ventilators use assist-control ventilation (ACV). They push air in on a set schedule. The baby can trigger breaths, but the machine mostly leads.
NAVA — which stands for neurally adjusted ventilatory assist — works differently. A tiny sensor in a feeding tube picks up the electrical signal from the baby's diaphragm (the muscle that drives breathing).
Every time the baby's brain tells the diaphragm to breathe, the machine delivers just the right amount of support. The baby leads. The machine follows.
Think of a dance partner. Old-school ventilators are like a partner who counts out loud and drags you around the floor. Your steps have to match theirs.
NAVA is the partner who feels where you want to go and supports the movement. You lead. They make it smoother.
For a baby with delicate lungs, that difference may matter a lot.
Researchers at two hospitals enrolled 11 newborns recovering from CDH surgery. Nine completed the trial.
Each baby spent 4 hours on NAVA and 4 hours on standard ACV, in random order. At the end of each block, doctors drew blood, measured oxygen, and recorded ventilator settings.
The main question — did NAVA give a better oxygenation index (OI, a number that tracks how hard the lungs are working to move oxygen)?
On NAVA, the average oxygenation index was 3.9. On standard ACV, it was 5.9. Lower is better — it means the lungs are working less hard.
That is a meaningful drop. The result was statistically solid (p = 0.008), which means it is unlikely to be chance.
The babies also needed lower airway pressures on NAVA. Peak pressure dropped from 22 to 17. Mean pressure dropped from 11.1 to 8.7. Tidal volumes — how much air moved with each breath — were gentler too.
This does not mean every CDH baby will get NAVA tomorrow.
Two babies could not start the trial because the diaphragm signal was too weak to pick up. That is an important limit of this technology.
The surprising shift
For decades, the goal with fragile newborn lungs was to take over the breathing. Control everything. Minimize the baby's work.
But research keeps showing that babies do better when the ventilator works with them, not around them. NAVA takes that idea further than any other mode.
The lower pressures seen here are especially important. High pressures can scar tiny lungs and slow recovery.
The authors say these results match earlier retrospective studies that hinted NAVA might help CDH babies. This is the first randomized trial in this group.
But they caution — a crossover trial with 9 babies is a first step. It shows the concept works. It does not yet prove NAVA leads to shorter NICU stays, fewer complications, or better long-term breathing.
Bigger trials are needed to answer those questions.
If your baby has CDH and is recovering in a NICU that offers NAVA, it may be worth asking the team whether it could be used. Not every hospital has it. The feeding-tube sensor and software are specialized.
If NAVA is not available, know that standard ventilators are still safe and effective. The care team's experience matters more than any single setting.
This research supports a conversation, not a demand. Parents and NICU teams can discuss what is right for each baby together.
Limitations to keep in mind
Only 11 babies were randomized, and 9 finished. That is a small group.
Each baby was their own comparison, which strengthens the math, but 4 hours on each mode is a short window. Longer-term outcomes — weaning, home discharge, lung health at age 1 — were not measured.
Two babies could not use NAVA at all because of a weak diaphragm signal. That is a real-world constraint.
Larger multi-center trials are the clear next step. Researchers want to know whether lower pressures and better oxygen numbers translate into shorter ventilator time, fewer infections, and healthier lungs months later.
There is also work to do on the sensor itself. Making it easier to get a reliable diaphragm signal in very small or sedated babies would open NAVA to more families.
For now, this study adds a careful, cautious piece of evidence. A smarter ventilator may give tiny lungs a gentler way to heal. And for families in a NICU waiting room, even a small step toward gentler is worth everything.